Navigation Links
FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
Date:6/13/2012

PHILADELPHIA, June 13, 2012 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today the acquisition of Phytone Ltd., a leading natural colors producer based in the United Kingdom.  Phytone's natural products and formulations are used by global customers in the food, beverage, personal care and nutrition sectors.

(Logo: http://photos.prnewswire.com/prnh/20111101/NE97440LOGO )

"This acquisition underscores our commitment to grow FMC's new natural colors portfolio, and represents another important step in our Vision 2015 growth strategy," said Pierre Brondeau, president, CEO and chairman, FMC Corporation.  "We expect the high-growth, natural colors market to reach well over $1 billion by 2015.  The addition of Phytone's unique color technology, coupled with our acquisition last year of Chilean-based South Pole Biogroup, greatly strengthens our position in this exciting market."

There is a growing demand from consumers that favor natural ingredients from renewable and sustainable sources, according to Mike Smith, division manager, FMC BioPolymer.  Consumer product goods companies are seeking reliable sources of natural ingredients with consistent functionality, including natural colors, to meet their product development needs. 

"Phytone further expands FMC's natural colors capabilities and augments FMC BioPolymer's industry leading, naturally sourced specialty ingredients that are used across food, pharmaceutical and personal care markets for texture, binding, stabilization and appearance," said Smith.

"We're excited to welcome Phytone to FMC," said Smith.  "The company brings more than 20 years of leadership and deep experience in the natural colors and nutraceuticals industry, and will extend FMC's natural color formulation and processing capabilities.  Furthermore, Phytone is ideally situated in the United Kingdom, which will enhance our service to European color customers."

Phytone's manufacturing, development labs and headquarters office are located in Staffordshire, U.K.  Terms of the transaction were not disclosed. 

About FMC Corporation
FMC Corporation is a diversified chemical company serving agricultural, industrial, environmental and consumer markets globally for more than a century with innovative solutions, applications and quality products.  In 2011, FMC had annual sales of approximately $3.4 billion.  The company employs approximately 5,000 people throughout the world, and operates its businesses in three segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals.  For more information, visit www.FMC.com

Safe Harbor Statement under the Private Securities Act of 1995: Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning specific factors described in FMC Corporation's 2011 Form 10-K and other SEC filings.  Such information contained herein represents management's best judgment as of the date hereof based on information currently available.  FMC Corporation does not intend to update this information and disclaims any legal obligation to the contrary.  Historical information is not necessarily indicative of future performance.

 

 


'/>"/>
SOURCE FMC Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
2. Centene Corporation Selected for Ohio Medicaid Contract
3. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
4. Ivera Medical Corporation Denies Patent Infringement Allegations
5. Comprehensive Care Corporation Implements Steps to Increase Margins and Sustain Profitability
6. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
7. With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation
8. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
9. Comprehensive Care Corporation Announces Profit for First Quarter
10. Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout
11. Henry Schein Ranks #303 In 2012 FORTUNE 500® Ranking Of Americas Largest Corporations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2017)...  Mako Medical Laboratories partnered with Secretary Strickland, the ... Fund (MFA) to bring 140 soldiers back home to ... families one last time before being deployed. Mako Medical ... logistics needed for these soldiers. "Mako Medical Laboratories is ... We just wish we could bring them all home," ...
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... Thomas Jefferson ... Witness , was awarded a $300,000 grant from The Pew Center for Arts ... with ambiguity and the recognition of one’s own limits among health professions students. ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... $5,000 grant from the C. R. Bard Foundation, Inc. to support ... Hills , a service available through the nonprofit home care agency. Using evidence-based ...
(Date:7/21/2017)... ... 21, 2017 , ... In the first prospective ACL reconstruction ... Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain a ... over time. The study, presented today at the American Orthopaedic Society for ...
(Date:7/20/2017)... MA (PRWEB) , ... July 20, 2017 , ... ... form of blood and bone marrow cancer that progresses rapidly without treatment. Newly ... recommended to reduce the chance of reoccurrence and relapse. With such a ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
Breaking Medicine News(10 mins):